glp-1 agonist diarrhea Managing GLP-1/GIP side effects with diet and lifestyle Effects of GLP-1 receptor agonist

If symptoms resolve with discontinuation and recur with rechallenge, alternative diabetes or weight management therapies should be considered

Tirzepatide is unique because it targets both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, making it a dual agonist

Measuring the correct dose is easy, but so is overmeasuring

This is about equity as much as anything else. Jonathan Saltzman can be reached at [email protected].

Multi-mechanism approaches can be more effective but also increase the risk of side effects and drug interactions

Dose Titration Dose adjustment guidelines of basal insulin or FRC used by the included trials are displayed in Table S4